Show simple item record

dc.contributor.authorLindsay, Colin R
dc.contributor.authorShaw, E. C.
dc.contributor.authorMoore, D. A.
dc.contributor.authorRassl, D.
dc.contributor.authorJamal-Hanjani, M.
dc.contributor.authorSteele, N.
dc.contributor.authorNaheed, S.
dc.contributor.authorDick, C.
dc.contributor.authorTaylor, F.
dc.contributor.authorAdderley, Helen
dc.contributor.authorBlack, F.
dc.contributor.authorSummers, Yvonne J
dc.contributor.authorEvans, M.
dc.contributor.authorRice, A.
dc.contributor.authorFabre, A.
dc.contributor.authorWallace, W. A.
dc.contributor.authorNicholson, S.
dc.contributor.authorHaragan, A.
dc.contributor.authorTaniere, P.
dc.contributor.authorNicholson, A. G.
dc.contributor.authorLaing, G.
dc.contributor.authorCave, J.
dc.contributor.authorForster, M. D.
dc.contributor.authorBlackhall, Fiona H
dc.contributor.authorGosney, J.
dc.contributor.authorPopat, S.
dc.contributor.authorKerr, K. M.
dc.date.accessioned2021-09-30T11:56:02Z
dc.date.available2021-09-30T11:56:02Z
dc.date.issued2021en
dc.identifier.citationLindsay CR, Shaw EC, Moore DA, Rassl D, Jamal-Hanjani M, Steele N, et al. Large cell neuroendocrine lung carcinoma: consensus statement from The British Thoracic Oncology Group and the Association of Pulmonary Pathologists. Br J Cancer. 2021 Sep 6.en
dc.identifier.pmid34489586en
dc.identifier.doi10.1038/s41416-021-01407-9en
dc.identifier.urihttp://hdl.handle.net/10541/624598
dc.description.abstractOver the past 10 years, lung cancer clinical and translational research has been characterised by exponential progress, exemplified by the introduction of molecularly targeted therapies, immunotherapy and chemo-immunotherapy combinations to stage III and IV non-small cell lung cancer. Along with squamous and small cell lung cancers, large cell neuroendocrine carcinoma (LCNEC) now represents an area of unmet need, particularly hampered by the lack of an encompassing pathological definition that can facilitate real-world and clinical trial progress. The steps we have proposed in this article represent an iterative and rational path forward towards clinical breakthroughs that can be modelled on success in other lung cancer pathologies.en
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1038/s41416-021-01407-9en
dc.titleLarge cell neuroendocrine lung carcinoma: consensus statement from The British Thoracic Oncology Group and the Association of Pulmonary Pathologistsen
dc.typeArticleen
dc.contributor.departmentDivision of Molecular and Clinical Cancer Sciences, University of Manchester, Manchester, UKen
dc.identifier.journalBritish Journal of Canceren
dc.description.noteen]
refterms.dateFOA2021-10-13T08:03:35Z


Files in this item

Thumbnail
Name:
34489586.pdf
Size:
1.497Mb
Format:
PDF
Description:
From UNPAYWALL

This item appears in the following Collection(s)

Show simple item record